Τεχνολογικές εξελίξεις & καινοτοµίες στις συσκευές βηµατοδότησης & απινίδωσης

Similar documents
Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, M.D.

FA et Apnée du Sommeil

Treatment of sleep apnea in heart failure patients after SERVE-HF results

Σύνδρομο σπνικής άπνοιας. Ποιός o ρόλος ηοσ ζηη γένεζη και ανηιμεηώπιζη ηων αρρσθμιών;

Martin R Cowie Professor of Cardiology, National Heart & Lung Institute Imperial College London (Royal Brompton Hospital)

About VirtuOx. Was marketed exclusively by Phillips Healthcare division, Respironics for 3 years

HF and CRT: CRT-P versus CRT-D

Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, MD, FHRS

Sleep Apnea and Heart Failure

A Deadly Combination: Central Sleep Apnea & Heart Failure

Edoardo Gronda UO cardiologia e Ricerca Dipartimento Cardiovascolare IRCCS MultiMedica

In-Patient Sleep Testing/Management Boaz Markewitz, MD

DRS ed Aritmie Cardiache Iper ed Ipocinetiche: la clinica

Apnea-Hypopnea- Index The new old biomarker for Sleep-Disordered Breathing. Alan S Maisel MD

Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter

The Effect of Sleep Disordered Breathing on Cardiovascular Disease

Follow-up of CRT patients ESC Munich Clinical and biological follow-up of CRT patients

Endpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD

Continuous ECG telemonitoring with implantable devices: the expected clinical benefits

PVDOMICS. Sleep Core. Cleveland Clinic Cleveland, Ohio

Cardiac Rhythm Therapy // Advanced Features // ProMRI. ProMRI. Checklist and Quick Reference Guide

How to treat Cardiac Resynchronization Therapy complications? C. Leclercq Departement of Cardiology Centre Cardio-Pneumologique Rennes, France

Heart Failure Challenges and Unmet needs

Mario Kinsella MD FAASM 10/5/2016

Improving Patient Outcomes with a Syncope Center. Suneet Mittal, MD

MRI SureScan pacemakers & ICDs what you need to know

ESC Guidelines. ESC Guidelines Update For internal training purpose. European Heart Journal, doi: /eurheart/ehn309

Integration of diagnostic device information to improve patient management

Large RCT s of CRT 2002 to present

Cardiac Resynchronization Therapy. Michelle Khoo, MD

Cardiac Implanted Electronic Devices Pacemakers, Defibrillators, Cardiac Resynchronization Devices, Loop Recorders, etc.

Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure

Sleep and the Heart. Physiologic Changes in Cardiovascular Parameters during Sleep

Sleep and the Heart. Rami N. Khayat, MD

Sleep and the Heart. Sleep Stages. Sleep and the Heart: non REM 8/31/2016

Preventing Sudden Death Current & Future Role of ICD Therapy

OHTAC Recommendation: Internet- Based Device-Assisted Remote Monitoring of Cardiovascular Implantable Electronic Devices

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy

Heart Failure and Sleep Disordered Breathing (SDB) Unhappy Bedfellows

ESC Stockholm Arrhythmias & pacing

MRI ACCESS. Evera MRI SureScan ICD Systems

Update on Device Innovation (S-ICD, Wearable, Leadless)

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

Obstructive Sleep Apnea

Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY. DISCLOSURE INFORMATION Arthur J.

The most accurate predictors of arterial hypertension in patients with Obstructive Sleep Apnea Syndrome

Sleep Disordered Breathing: Beware Snoring! Dr T A McDonagh Consultant Cardiologist Royal Brompton Hospital London. UK

The Counter HF Clinical Study for Heart Failure

Circadian Variations Influential in Circulatory & Vascular Phenomena

Sleep Apnea: Vascular and Metabolic Complications

Μηνύματα από τις σπουδαιότερες μελέτες στην ηλεκτροφυσιολογία το διάστημα

Sleep and the Heart Reversing the Effects of Sleep Apnea to Better Manage Heart Disease

How to prevent unecessary right ventricular pacing

BSH Annual Autumn Meeting 2017

ESC/EHRA. Guidelines on Cardiac Pacing. Panos E. Vardas Professor of Cardiology Heraklion University Hospital Crete, Greece

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Implantable Cardiac Monitors for Atrial Fibrillation (AF) Detection: Ready for Routine Use?

INNOVATIONS IN DEVICE THERAPY:

How to set up a device clinic for heart failure patients Dr C Sridevi

OSA and cardiovascular disease what is the evidence? Mohan Edupuganti, MD, FACC. Baptist Health Cardiology. Disclosures: None

CRT: whom does it benefit?

Bi-Ventricular pacing after the most recent studies

MRI conditional devices. A luxury or a real clinical need? Sophie Mavrogeni, MD, FESC Onassis Cardiac Surgery Center, Athens, Greece

Slide 1. Slide 2 Declaration of Interests. Slide 3. Case study #1. Heart Failure and Sleep Apnoea. 47 year old BMI 32 Treated HBP Type 2 DM

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

Heart Rhythm Disorders. How do you quantify risk?

Gender and cardiac resynchronization therapy. Chairs: David Heaven & Belinda Green. Gender and Cardiac Resynchronisation Therapy

Cardiac Resynchronization Therapy Guidelines and Missing Groups

2/19/2013. Cardiovascular Disease Prevention International Symposium. Cardiovascular Disease and Sleep Apnea. Still Controversial?

ESC CONGRESS HIGHLIGHTS ARRHYTHMIAS. M. Bertini (Ferrara, IT) Conflicts of Interest none

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

Primary prevention of SCD with the ICD in Nonischemic Cardiomyopathy

All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, MFMER

Chapter 4: Cardiovascular Disease in Patients With CKD

ROBERT C. PRITCHARD DIRECTOR MICHAEL O. FOSTER ASSISTANT DIR. SLEEP APNEA

Risk prediction in inherited conditions Laminopathies

Device detected VT: How much VT is significant and is VT ablation the answer?

Cardiac resynchronisation therapy (biventricular pacing) for the treatment of heart failure

Atrial Fibrillation. Damage to your heart caused by a heart attack or rheumatic heart disease

Mohammad Zubaid, MB, ChB, FRCPC, FACC

CARDIAC DEVICE MR-CONDITIONAL PRODUCT SUMMARY CHART

2016 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older)

עדכונים באלקטרופיזיולוגיה Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev

THE ROLE OF ICD THERAPY FOR PRIMARY PREVENTION Leonard Ganz, M.D. Pittsburgh, PA

Cardiac Rhythm Device Management. PBL STOP Your acronym for a standardized follow-up

Device based CRT optimization: is there a future? Lessons learned from published trials

How We Breathe During Sleep Affects Health, Wellness and Longevity

Response of Right Ventricular Size to Treatment with Cardiac Resynchronization Therapy and the Risk of Ventricular Tachyarrhythmias in MADIT-CRT

Sudden Death in Athletes: What is the role of ECG Screening?

GOALS. Obstructive Sleep Apnea and Cardiovascular Disease (OVERVIEW) FINANCIAL DISCLOSURE 2/1/2017

Heart Rhythm Congress 2016 Chronotropic incompetence in heart failure patients

Dipartimento di Scienze Cardiovascolari Università Campus Bio-Medico di Roma Dott. Vito Calabrese

Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2016

Case. Case. Case. Sleep Disorders: A Case-based Approach. LeRoy Essig, MD Rami Khayat, MD ROS:

Central Sleep Apnoea during CPAP therapy First insights from a big data analysis. April 2018

Multisite Left Ventricular Pacing for Cardiac Resynchronization

Inspire Therapy for Sleep Apnea

Understanding Atrial Fibrillation A guide for patients

Evera MRI XT SureScan ICD SYSTEM

Transcription:

Τεχνολογικές εξελίξεις & καινοτοµίες στις συσκευές βηµατοδότησης & απινίδωσης Georgios Giannopoulos, MD, FESC Cardiology Dept., Athens General Hospital G. Gennimatas, Athens, Greece Adj. Asst. Professor of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT, USA e-mail: ggiann@med.uoa.gr; georgios.giannopolous@yale.edu web: http://www.researchgate.net/profile/georgios_giannopoulos2 Tuesday, March 10, 15

J Am Coll Cardiol 2006 Perception: mortality rate is 50% in 5 years in patients with heart failure Reality: this was true of early CRT experience, but has dramatically changed over time Tuesday, March 10, 15

In MADIT-CRT, at 7 years, >80% of CRT-D patients with LBBB were alive Danish Registry: median survival after CRT QRS 120-149: 95 months (7.9 years) QRS 150-199: 82.2 months (6.9 years) QRS 200: 70.0 months (5.8 years) Tuesday, March 10, 15

Impact of increased ICD/CRT longevity on costs

ICD and CRT-D Battery Longevity: savings

CRT-D Battery Longevity: Closing the Gap

CRT-D Battery Longevity: Closing the Gap

MRI with MR conditional devices

MRI with MR conditional devices

Going up to 3T

Going up to 3T

Going up to 3T

Clinical use of 3T is increasing While 1.5 T machines remain the clinical standard, 3.0 T MRI scanners improve image quality and reduce scan time. Higher definition 3T MRI scans help physicians see intricate details in soft tissue, for example in the brain! Useful for acute stroke, TIA, brain tumors. Shorter scan times are helpful for patients who experience claustrophobia or have difficulty remaining motionless, such as young children 25% of new MRI machine installations are 3T 7. Advancements in MRI imaging technologies, Demand for non-invasive and ionizing radiationfree diagnostic procedures are a few growth drivers Tuesday, March 10, 15

Clinical use of 3T is increasing While 1.5 T machines remain the clinical standard, 3.0 T MRI scanners improve image quality and reduce scan time. Higher definition 3T MRI scans help physicians see intricate details in soft tissue, for example in the brain! Useful for acute stroke, TIA, brain tumors. Shorter scan times are helpful for patients who experience claustrophobia or have difficulty remaining motionless, such as young children 25% of new MRI machine installations are 3T 7. Advancements in MRI imaging technologies, Demand for non-invasive and ionizing radiationfree diagnostic procedures are a few growth drivers Tuesday, March 10, 15

` Tuesday, March 10, 15

If ICDs were even smaller, what benefits do you think that could have? Tuesday, March 10, 15

If ICDs were even smaller, what benefits do you think that could have? Tuesday, March 10, 15

Smaller generator " Easier to fit for replacements " Smaller incision for initial implant " Lower risk of pocket-related complication " Lower skin pressure " More options to offer patients Tuesday, March 10, 15

ICD Volume Thinness MINI 1 26.5cc 9.9mm MDT Evera 2 33.0cc 13.0mm STJ Ellipse 3 30.0cc 12.0mm BIO Iforia 4 29.9cc 11.0mm SORIN Paradym 5 39.9cc 11.0mm MINI ICD VR is 20% smaller and 24% thinner than Evera TM VR. 1 MINI ICD: Boston Scientific Physician Technical Manual 359060-01 EN Europe 2013-04. 2 EVERA XT VR DVBB1D4 2013 3 St. Jude Medical High-Voltage Devices User s Manual 2013 page 16. 4 Biotronik Iforia TM 3/5/7 Manual 13-X-20 Revision: D(2013-04-29) 5 Sorin Paradym TM RF VR model 9250 Implant manual 0561C-en-2011-03 Tuesday, March 10, 15

ICD Volume Thinness MINI 1 26.5cc 9.9mm Battery and Capacitor make up 2/3rds of ICD size Industry Avg. MINI VR 4.5 5.6 5.4 DR 3.3 5.8 5.1 MDT Evera 2 33.0cc 13.0mm STJ Ellipse 3 30.0cc 12.0mm BIO Iforia 4 29.9cc 11.0mm SORIN Paradym 5 39.9cc 11.0mm MINI ICD VR is 20% smaller and 24% thinner than Evera TM VR. 1 MINI ICD: Boston Scientific Physician Technical Manual 359060-01 EN Europe 2013-04. 2 EVERA XT VR DVBB1D4 2013 3 St. Jude Medical High-Voltage Devices User s Manual 2013 page 16. 4 Biotronik Iforia TM 3/5/7 Manual 13-X-20 Revision: D(2013-04-29) 5 Sorin Paradym TM RF VR model 9250 Implant manual 0561C-en-2011-03 Tuesday, March 10, 15

Question Which pathology has up to 80% prevalence in HF population, with about 80% remaining undiagnosed, is linked to several clinical major events and has therapeutical options available? Tuesday, March 10, 15

increased hypoxia autonomic distress (from hypoxia) decreased ejection fraction increased LV afterload decreased cardiac output increased heart rate increased blood pressure

Sleep Apnea and cardiovascular consequences

Sleep Apnea and cardiovascular consequences Heart Failure Mortality HF mortality increased by 2-fold. Worsened survival in HF patients with untreated sleep apnea vs. no or mild Sleep Apnea patients (76% vs. 88%). Increased survival for treated sleep apnea. Heart Failure Morbidity OSA can lead to a progression of HF and refractoriness to therapy. OSA increases HF morbidity by 2.2- fold. Cardiovascular Events Severe OSA increased risk of fatal cardiovascular events by 3-fold. Tuesday, March 10, 15

Sleep Apnea and cardiovascular consequences Sudden Death Sleep Apnea increases risk for VT/VF & appropriate ICD therapies by 2-3 fold. Sleep Apnea increases risk of nocturnal SCD compared to daytime (RR: 2.57). Event-free survival from appropriate ICD therapies in HF population with CSA, OSA, no or mild SDB Atrial Fibrillation Sleep Apnea is an independent predictor of new onset AF, and may be a causative factor in the development of AF. Sleep Apnea increases likelihood for AF recurrence post cardioversion (from 42% to 82%). Recurrence decreases after CPAP therapy. Bitter, EHJ 2011 Tuesday, March 10, 15 Mehra, AJRCCM 2006

Butt et al. Circ Heart Fail. 2012

Butt et al. Circ Heart Fail. 2012

Butt et al. Circ Heart Fail. 2012 Colish, CHEST 2012 Tuesday, March 10, 15

Screening for apnea

Screening for apnea

AP Scan /ApneaScan allow you to identify implanted patients at risk of severe sleep apnea, who may benefit from further investigation and potential better treatment.! AP Scan /ApneaScan displays the average number of Respiratory Disturbance Events (RDE) per hour that the patient experiences during the programmed sleep period.! The number of occurred RDE define the different grade of sleep-disordered breathing. Severe sleepdisordered breathing is identified with > 30 Events/hr.! AP Scan on PM population showed the following performance 145 :! RDE is correlated with clinical AHI (R=0.8)! with 82% sensitivity and 88% specificity! and 88% PPV in identifying Severe Sleep Apnea patients (AHI >= 30) Tuesday, March 10, 15

AP Scan /ApneaScan allow you to identify implanted patients at risk of severe sleep apnea, who may benefit from further investigation and potential better treatment.! AP Scan /ApneaScan displays the average number of Respiratory Disturbance Events (RDE) per hour that the patient experiences during the programmed sleep period.! The number of occurred RDE define the different grade of sleep-disordered breathing. Severe sleepdisordered breathing is identified with > 30 Events/hr.! AP Scan on PM population showed the following performance 145 :! RDE is correlated with clinical AHI (R=0.8)! with 82% sensitivity and 88% specificity! and 88% PPV in identifying Severe Sleep Apnea patients (AHI >= 30) Tuesday, March 10, 15

AP Scan /ApneaScan allow you to identify implanted patients at risk of severe sleep apnea, who may benefit from further investigation and potential better treatment.! AP Scan /ApneaScan displays the average number of Respiratory Disturbance Events (RDE) per hour that the patient experiences during the programmed sleep period.! The number of occurred RDE define the different grade of sleep-disordered breathing. Severe sleepdisordered breathing is identified with > 30 Events/hr.! AP Scan on PM population showed the following performance 145 :! RDE is correlated with clinical AHI (R=0.8)! with 82% sensitivity and 88% specificity! and 88% PPV in identifying Severe Sleep Apnea patients (AHI >= 30) Tuesday, March 10, 15

Diagnostic-Therapeutic Pathway

My insurance plan didn t have coverage for a regular pacemaker